1 - 25 of
47
results
for author:"Ohki M."
in Literature Citations
| Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Nakamura Y., Migita T., Hosoda F., Okada N., Gotoh M., Arai Y., Fukushima M., Ohki M., Miyata S., Takeuchi K. et al. Int. J. Cancer 125:1859-1867(2009) · Mapped (2) |
| Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Yamazaki K., Takamura M., Masugi Y., Mori T., Du W., Hibi T., Hiraoka N., Ohta T., Ohki M., Hirohashi S. et al. Lab. Invest. 89:425-432(2009) · Mapped (17) |
| A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Kurosu T., Tsuji K., Ohki M., Miki T., Yamamoto M., Kakihana K., Koyama T., Taniguchi S., Miura O. Int. J. Hematol. 88:192-196(2008) · Mapped (33) |
| Expression profile of early lung adenocarcinoma: identification of MRP3 as a molecular marker for early progression. Hanada S., Maeshima A., Matsuno Y., Ohta T., Ohki M., Yoshida T., Hayashi Y., Yoshizawa Y., Hirohashi S., Sakamoto M. J. Pathol. 216:75-82(2008) · Mapped (7) |
| The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. Heissig B., Lund L.R., Akiyama H., Ohki M., Morita Y., Romer J., Nakauchi H., Okumura K., Ogawa H., Werb Z. et al. Cell Stem Cell 1:658-670(2007) · Mapped (8) |
| GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Saeki N., Kim D.H., Usui T., Aoyagi K., Tatsuta T., Aoki K., Yanagihara K., Tamura M., Mizushima H., Sakamoto H. et al. |
| The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Ishida M., Miyamoto M., Naitoh S., Tatsuda D., Hasegawa T., Nemoto T., Yokozeki H., Nishioka K., Matsukage A., Ohki M. et al. Mol. Cell. Biol. 27:1348-1355(2007) · Mapped (24) |
| Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells. Usui T., Aoyagi K., Saeki N., Nakanishi Y., Kanai Y., Ohki M., Ogawa K., Yoshida T., Sasaki H. Int. J. Oncol. 29:779-784(2006) · Mapped (4) |
| The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage. Masuda Y., Futamura M., Kamino H., Nakamura Y., Kitamura N., Ohnishi S., Miyamoto Y., Ichikawa H., Ohta T., Ohki M. et al. J. Hum. Genet. 51:652-664(2006) · Mapped (53) |
| Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Kohno T., Sakiyama T., Kunitoh H., Goto K., Nishiwaki Y., Saito D., Hirose H., Eguchi T., Yanagitani N., Saito R. et al. Carcinogenesis 27:2448-2454(2006) · Mapped (3) |
| Memory trace of motor learning shifts transsynaptically from cerebellar cortex to nuclei for consolidation. Shutoh F., Ohki M., Kitazawa H., Itohara S., Nagao S. Neuroscience 139:767-777(2006) · Mapped (2) |
| ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Takada H., Imoto I., Tsuda H., Nakanishi Y., Ichikura T., Mochizuki H., Mitsufuji S., Hosoda F., Hirohashi S., Ohki M. et al. Oncogene 24:8051-8060(2005) · Mapped (7) |
| Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Sakiyama T., Kohno T., Mimaki S., Ohta T., Yanagitani N., Sobue T., Kunitoh H., Saito R., Shimizu K., Hirama C. et al. Int. J. Cancer 114:730-737(2005) · Mapped (39) |
| First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability. Shimada H., Shimizu K., Mimaki S., Sakiyama T., Mori T., Shimasaki N., Yokota J., Nakachi K., Ohta T., Ohki M. Hum. Genet. 115:372-376(2004) · UniProtKB (1) |
| Physical and functional link of the leukemia-associated factors AML1 and PML. Nguyen L.A., Pandolfi P.P., Aikawa Y., Tagata Y., Ohki M., Kitabayashi I. Blood 105:292-300(2005) · Mapped (20) |
| Altered gene expression in the adult brain of fyn-deficient mice. Goto J., Tezuka T., Nakazawa T., Tsukamoto N., Nakamura T., Ajima R., Yokoyama K., Ohta T., Ohki M., Yamamoto T. Cell. Mol. Neurobiol. 24:149-159(2004) · Mapped (1) |
| Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Tsuchiya A., Sakamoto M., Yasuda J., Chuma M., Ohta T., Ohki M., Yasugi T., Taketani Y., Hirohashi S. Am. J. Pathol. 163:2503-2512(2003) · Mapped (3) |
| Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease. Takagi M., Tsuchida R., Oguchi K., Shigeta T., Nakada S., Shimizu K., Ohki M., Delia D., Chessa L., Taya Y. et al. Blood 103:283-290(2004) · Mapped (8) |
| Role of protein kinase C family in the cerebellum-dependent adaptive learning of horizontal optokinetic response eye movements in mice. Shutoh F., Katoh A., Ohki M., Itohara S., Tonegawa S., Nagao S. Eur. J. Neurosci. 18:134-142(2003) · Mapped (3) |
| Overexpression of KIT in chromophobe renal cell carcinoma. Yamazaki K., Sakamoto M., Ohta T., Kanai Y., Ohki M., Hirohashi S. Oncogene 22:847-852(2003) · Mapped (6) |
| A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK). Yanagisawa K., Tago K., Hayakawa M., Ohki M., Iwahana H., Tominaga S. |
| Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Yokoyama A., Kitabayashi I., Ayton P.M., Cleary M.L., Ohki M. Blood 100:3710-3718(2002) · Mapped (28) |
| G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Tachibana M., Sugimoto K., Nozaki M., Ueda J., Ohta T., Ohki M., Fukuda M., Takeda N., Niida H., Kato H. et al. |
| A pediatric case of secondary leukemia associated with t(16;21)(q24;q22) exhibiting the chimeric AML1-MTG16 gene. Kondoh K., Nakata Y., Furuta T., Hosoda F., Gamou T., Kurosawa Y., Kinoshita A., Ohki M., Tomita Y., Mori T. Leuk. Lymphoma 43:415-420(2002) · Mapped (4) |
| Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis. Shimada H., Ichikawa H., Ohki M. Leukemia 16:874-885(2002) · Mapped (23) |
